Waiting now for the announcement which says the human clinical trial for asthma can go ahead, given the safety of Cymerus MSC's in humans as demonstrated by the results of the safety review board for the study into GvHD (expected in January).
Ann: Final Preclinical Asthma Study Confirms Efficacy, page-9
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
-0.005(2.13%) |
Mkt cap ! $41.55M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 23.5¢ | 23.0¢ | $18.19K | 78.25K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 62836 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 15000 | 3 |
View Market Depth
| Last trade - 13.38pm 04/11/2024 (20 minute delay) ? |
| CYP (ASX) Chart |